A nurse is monitoring a client who has acute kidney injury. which of the following laboratory

1. KDIGO Clinical Practice Guideline for Acute Kidney Injury Section 2: AKI Definition. Kidney Int Suppl. 2012;2:19–36. [Google Scholar]

2. KDIGO Clinical Practice Guideline for Acute Kidney Injury Section 3: Prevention and Treatment of AKI. Kidney Int Suppl. 2012;2:37–68. [Google Scholar]

3. Chawla L.S., Bellomo R., Bihorac A. Acute kidney disease and renal recovery: guideline report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Clin J Am Soc Nephrol. 2017;13:241–257. [PubMed] [Google Scholar]

4. Chawla L.S., Bellomo R., Bihorac A. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Worgroup. Nat Rev Nephrol. 2017;13:241–257. [PubMed] [Google Scholar]

5. Mehta R.L., Burdmann E.A., Cerda J. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet (London, England) 2016;387:2017–2025. [PubMed] [Google Scholar]

6. Kellum J.A., Bellomo R., Ronco C. Acute Dialysis Quality Initiative (ADQI): methodology. Int J Artif Organs. 2008;31:90–93. [PubMed] [Google Scholar]

7. Bouchard J., Soroko S.B., Chertow G.M. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422–427. [PubMed] [Google Scholar]

8. Osman D., Ridel C., Ray P. Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med. 2007;35:64–68. [PubMed] [Google Scholar]

9. Feissel M., Teboul J.L., Merlani P. Plethysmographic dynamic indices predict fluid responsiveness in septic ventilated patients. Intensive Care Med. 2007;33:993–999. [PubMed] [Google Scholar]

10. Gruenewald M., Meybohm P., Koerner S. Dynamic and volumetric variables of fluid responsiveness fail during immediate postresuscitation period. Crit Care Med. 2011;39:1953–1959. [PubMed] [Google Scholar]

11. Finfer S., Vincent J.L. Critical care–an all-encompassing specialty. N Engl J Med. 2013;369:669–670. [PubMed] [Google Scholar]

12. Starling E.H. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19:312–326. [PMC free article] [PubMed] [Google Scholar]

13. Varadhan K.K., Lobo D.N. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc. 2010;69:488–498. [PubMed] [Google Scholar]

14. Perner A., Haase N., Guttormsen A.B. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124–134. [PubMed] [Google Scholar]

15. Myburgh J.A., Finfer S., Bellomo R. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–1911. [PubMed] [Google Scholar]

16. Quinlan G.J., Martin G.S., Evans T.W. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41:1211–1219. [PubMed] [Google Scholar]

17. Weil M.H., Henning R.J., Puri V.K. Colloid oncotic pressure: clinical significance. Crit Care Med. 1979;7:113–116. [PubMed] [Google Scholar]

18. Sudlow G., Birkett D.J., Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol. 1975;11:824–832. [PubMed] [Google Scholar]

19. King T.P. On the sulfhydryl group of human plasma albumin. J Biol Chem. 1961;236:PC5. [PubMed] [Google Scholar]

20. Quinlan G.J., Margarson M.P., Mumby S. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998;95:459–465. [PubMed] [Google Scholar]

21. Finfer S., Bellomo R., Boyce N. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–2256. [PubMed] [Google Scholar]

22. Caironi P., Tognoni G., Masson S. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412–1421. [PubMed] [Google Scholar]

23. Wills B.A., Nguyen M.D., Ha T.L. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005;353:877–889. [PubMed] [Google Scholar]

24. Hadimioglu N., Saadawy I., Saglam T. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg. 2008;107:264–269. [PubMed] [Google Scholar]

25. Hasman H., Cinar O., Uzun A. A randomized clinical trial comparing the effect of rapidly infused crystalloids on acid-base status in dehydrated patients in the emergency department. Int J Med Sci. 2012;9:59–64. [PMC free article] [PubMed] [Google Scholar]

26. Khajavi M.R., Etezadi F., Moharari R.S. Effects of normal saline vs. lactated ringer's during renal transplantation. Ren Fail. 2008;30:535–539. [PubMed] [Google Scholar]

27. Wilcox C.S. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726–735. [PMC free article] [PubMed] [Google Scholar]

28. Shaw A.D., Bagshaw S.M., Goldstein S.L. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012;255:821–829. [PubMed] [Google Scholar]

29. Yunos N.M., Bellomo R., Hegarty C. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566–1572. [PubMed] [Google Scholar]

30. McCluskey S.A., Karkouti K., Wijeysundera D. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg. 2013;117:412–421. [PubMed] [Google Scholar]

31. Young P., Bailey M., Beasley R. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314:1701–1710. [PubMed] [Google Scholar]

32. Rivers E., Nguyen B., Havstad S. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377. [PubMed] [Google Scholar]

33. Dellinger R.P., Levy M.M., Carlet J.M. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327. [PubMed] [Google Scholar]

34. Pro C.I., Yealy D.M., Kellum J.A. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683–1693. [PMC free article] [PubMed] [Google Scholar]

35. ARISE Investigators; ANZICS Clinical Trials Group. Peake S.L. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496–1506. [PubMed] [Google Scholar]

36. Mouncey P.R., Osborn T.M., Power G.S. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301–1311. [PubMed] [Google Scholar]

37. Ranjit S., Kissoon N., Gandhi D. Early differentiation between dengue and septic shock by comparison of admission hemodynamic, clinical, and laboratory variables: a pilot study. Pediatr Emerg Care. 2007;23:368–375. [PubMed] [Google Scholar]

38. Maitland K., Kiguli S., Opoka R.O. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364:2483–2495. [PubMed] [Google Scholar]

39. Goldstein S.L., Somers M.J., Baum M.A. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int. 2005;67:653–658. [PubMed] [Google Scholar]

40. Foland J.A., Fortenberry J.D., Warshaw B.L. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004;32:1771–1776. [PubMed] [Google Scholar]

41. Gillespie R.S., Seidel K., Symons J.M. Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol. 2004;19:1394–1399. [PubMed] [Google Scholar]

42. Hayes L.W., Oster R.A., Tofil N.M. Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care. 2009;24:394–400. [PubMed] [Google Scholar]

43. Michael M., Kuehnle I., Goldstein S.L. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol. 2004;19:91–95. [PubMed] [Google Scholar]

44. Selewski D.T., Cornell T.T., Blatt N.B. Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy. Crit Care Med. 2012;40:2694–2699. [PMC free article] [PubMed] [Google Scholar]

45. de Galasso L., Emma F., Picca S. Continuous renal replacement therapy in children: fluid overload does not always predict mortality. Pediatr Nephrol. 2016;31:651–659. [PubMed] [Google Scholar]

46. De Backer D., Biston P., Devriendt J. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779–789. [PubMed] [Google Scholar]

47. Delmas A., Leone M., Rousseau S. Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care. 2005;9:212–222. [PMC free article] [PubMed] [Google Scholar]

48. Russell J.A., Walley K.R., Singer J. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–887. [PubMed] [Google Scholar]

49. Gordon A.C., Russell J.A., Walley K.R. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 2010;36:83–91. [PubMed] [Google Scholar]

50. Dellinger R.P., Levy M.M., Rhodes A. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637. [PubMed] [Google Scholar]

51. LeDoux D., Astiz M.E., Carpati C.M. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 2000;28:2729–2732. [PubMed] [Google Scholar]

52. Dunser M.W., Takala J., Ulmer H. Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009;35:1225–1233. [PubMed] [Google Scholar]

53. Asfar P., Meziani F., Hamel J.F. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583–1593. [PubMed] [Google Scholar]

54. Salmasi V., Maheshwari K., Yang Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery. Anesthesiology. 2017;126:47–65. [PubMed] [Google Scholar]

55. Sun L.Y., Wijeysundera D.N., Tait G.A., Beattie W.S. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123:515–523. [PubMed] [Google Scholar]

56. Onuigbo M.A.C., Agbasi N. Intraoperative hypotension - a negalected causative factor in hospital-acquired acute kidney injury;a Mayo Clinic Health System experience revisited. J Renal Inj Prev. 2015;4:61–67. [PMC free article] [PubMed] [Google Scholar]

57. Mehta R.L., McDonald B., Gabbai F. Nephrology consultation in acute renal failure: does timing matter? Am J Med. 2002;113:456–461. [PubMed] [Google Scholar]

58. Costa e Silva V.T., Liano F., Muriel A. Nephrology referral and outcomes in critically ill acute kidney injury patients. PLoS One. 2013;8:e70482. [PMC free article] [PubMed] [Google Scholar]

59. Ponce D., Zorzenon Cde P., dos Santos N.Y. Early nephrology consultation can have an impact on outcome of acute kidney injury patients. Nephrol Dial Transplant. 2011;26:3202–3206. [PubMed] [Google Scholar]

60. Meier P., Bonfils R.M., Vogt B. Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury. Clin J Am Soc Nephrol. 2011;6:2215–2225. [PMC free article] [PubMed] [Google Scholar]

61. Kaufman J., Dhakal M., Patel B. Community-acquired acute renal failure. Am J Kidney Dis. 1991;17:191–198. [PubMed] [Google Scholar]

62. Wu T.Y., Jen M.H., Bottle A. Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009. J R Soc Med. 2010;103:239–250. [PMC free article] [PubMed] [Google Scholar]

63. Lameire N., Van Biesen W., Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol. 2006;2:364–377. [PubMed] [Google Scholar]

64. Bagshaw S.M., George C., Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care. 2007;11:R68. [PMC free article] [PubMed] [Google Scholar]

65. Mizock B.A. The multiple organ dysfunction syndrome. Dis Mon. 2009;55:476–526. [PubMed] [Google Scholar]

66. Proulx F., Joyal J.S., Mariscalco M.M. The pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med. 2009;10:12–22. [PubMed] [Google Scholar]

67. Lewis S.J., Mueller B.A. Antibiotic dosing in patients with acute kidney injury: “enough but not too much” J Intensive Care Med. 2016;31:164–176. [PubMed] [Google Scholar]

68. Eyler R.F., Mueller B.A. Medscape. Antibiotic dosing in critically ill patients with acute kidney injury. Nat Rev Nephrol. 2011;7:226–235. [PubMed] [Google Scholar]

69. Mehta R.L., Pascual M.T., Soroko S. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004;66:1613–1621. [PubMed] [Google Scholar]

70. KDIGO Clinical Practice Guideline for Acute Kidney Injury Section 4: Contrast-induced AKI. Kidney Int Suppl. 2012;2:69–88. [PMC free article] [PubMed] [Google Scholar]

71. Cosgrove S.E., Vigliani G.A., Fowler V.G., Jr. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009;48:713–721. [PubMed] [Google Scholar]

72. Falagas M.E., Matthaiou D.K., Bliziotis I.A. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother. 2006;57:639–647. [PubMed] [Google Scholar]

73. Falagas M.E., Matthaiou D.K., Karveli E.A. Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections. Aliment Pharmacol Ther. 2007;25:537–556. [PubMed] [Google Scholar]

74. Glasmacher A., von Lilienfeld-Toal M., Schulte S. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients. Clin Microbiol Infect. 2005;11 Suppl 5:17–23. [PubMed] [Google Scholar]

75. Paul M., Benuri-Silbiger I., Soares-Weiser K. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ. 2004;328:668. [PMC free article] [PubMed] [Google Scholar]

76. James M., Bouchard J., Ho J. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61:673–685. [PubMed] [Google Scholar]

77. Ad-hoc Working Group of ERBP. Fliser D., Laville M. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27:4263–4272. [PMC free article] [PubMed] [Google Scholar]

78. Blakeman T., Harding S., O'Donoghue D. Acute kidney injury in the community: why primary care has an important role. Br J Gen Pract. 2013;63:173–174. [PMC free article] [PubMed] [Google Scholar]

79. Bouchard J., Macedo E., Soroko S. Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. Nephrol Dial Transplant. 2010;25:102–107. [PMC free article] [PubMed] [Google Scholar]

80. Jelliffe R. Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen. Am J Nephrol. 2002;22:320–324. [PubMed] [Google Scholar]

81. Brater D.C. ADIS Health Science Press; Balgowlah, Australia: 1983. Drug Use in Renal Disease. [Google Scholar]

82. Macedo E., Bouchard J., Soroko S.H. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care. 2010;14:R82. [PMC free article] [PubMed] [Google Scholar]

83. Roberts D.M., Roberts J.A., Roberts M.S. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med. 2012;40:1523–1528. [PubMed] [Google Scholar]

84. Lanese D.M., Alfrey P.S., Molitoris B.A. Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers. Kidney Int. 1989;35:1409–1412. [PubMed] [Google Scholar]

85. Barth R.H., DeVincenzo N. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy. Kidney Int. 1996;50:929–936. [PubMed] [Google Scholar]

86. Hager B., Betschart M., Krapf R. Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr. 1996;126:666–673. [PubMed] [Google Scholar]

87. Lassnigg A., Donner E., Grubhofer G. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97–104. [PubMed] [Google Scholar]

88. Mahesh B., Yim B., Robson D. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg. 2008;33:370–376. [PubMed] [Google Scholar]

89. Ho K.M., Power B.M. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010;65:283–293. [PubMed] [Google Scholar]

90. Cantarovich F., Fernandez J.C., Locatelli A. Frusemide in high doses in the treatment of acute renal failure. Postgrad Med J. 1971;47 Suppl:13–17. [PubMed] [Google Scholar]

91. Letter: high-dose frusemide in renal failure. BMJ. 1974;2:278–279. [PMC free article] [PubMed] [Google Scholar]

92. Kleinknecht D., Ganeval D., Gonzalez-Duque L.A. Furosemide in acute oliguric renal failure. A controlled trial. Nephron. 1976;17:51–58. [PubMed] [Google Scholar]

93. Brown C.B., Ogg C.S., Cameron J.S. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol. 1981;15:90–96. [PubMed] [Google Scholar]

94. Shilliday I.R., Quinn K.J., Allison M.E. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592–2596. [PubMed] [Google Scholar]

95. Cantarovich F., Rangoonwala B., Lorenz H. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis. 2004;44:402–409. [PubMed] [Google Scholar]

96. van der Voort P.H., Boerma E.C., Koopmans M. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med. 2009;37:533–538. [PubMed] [Google Scholar]

97. Ho K.M., Sheridan D.J. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006;333:420. [PMC free article] [PubMed] [Google Scholar]

98. Lapi F., Azoulay L., Yin H. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525. [PMC free article] [PubMed] [Google Scholar]

99. Chawla L.S., Davison D.L., Brasha-Mitchell E. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17:R207. [PMC free article] [PubMed] [Google Scholar]

100. Koyner J.L., Davison D.L., Brasha-Mitchell E. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol. 2015;26:2023–2031. [PMC free article] [PubMed] [Google Scholar]

101. Fouque D., Kalantar-Zadeh K., Kopple J. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398. [PubMed] [Google Scholar]

102. Fiaccadori E., Lombardi M., Leonardi S. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. J Am Soc Nephrol. 1999;10:581–593. [PubMed] [Google Scholar]

103. Fiaccadori E., Cremaschi E., Regolisti G. Nutritional assessment and delivery in renal replacement therapy patients. Semin Dial. 2011;24:169–175. [PubMed] [Google Scholar]

104. Kritmetapak K., Peerapornratana S., Srisawat N. The impact of macro−and micronutrients on predicting outcomes of critically ill patients requiring continuous renal replacement therapy. PLoS One. 2016;11:e0156634. [PMC free article] [PubMed] [Google Scholar]

105. Fiaccadori E., Maggiore U., Cabassi A. Nutritional evaluation and management of AKI patients. J Ren Nutr. 2013;23:255–258. [PubMed] [Google Scholar]

106. Braunschweig C.L., Levy P., Sheean P.M. Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr. 2001;74:534–542. [PubMed] [Google Scholar]

107. Gramlich L., Kichian K., Pinilla J. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition. 2004;20:843–848. [PubMed] [Google Scholar]

108. Peter J.V., Moran J.L., Phillips-Hughes J. A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients. Crit Care Med. 2005;33:213–220. discussion 260–211. [PubMed] [Google Scholar]

109. Simpson F., Doig G.S. Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle. Intensive Care Med. 2005;31:12–23. [PubMed] [Google Scholar]

110. Casaer M.P., Mesotten D., Hermans G. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506–517. [PubMed] [Google Scholar]

111. Heyland D.K., Dhaliwal R., Drover J.W. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003;27:355–373. [PubMed] [Google Scholar]

112. Singer P., Berger M.M., Van den Berghe G. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr. 2009;28:387–400. [PubMed] [Google Scholar]

113. Martindale R.G., McClave S.A., Vanek V.W. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care. Med. 2009;37:1757–1761. [PubMed] [Google Scholar]

114. Scheinkestel C.D., Kar L., Marshall K. Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition. 2003;19:909–916. [PubMed] [Google Scholar]

115. Fiaccadori E., Maggiore U., Clima B. Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Kidney Int. 2001;59:1510–1519. [PubMed] [Google Scholar]

116. Metnitz P.G., Krenn C.G., Steltzer H. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002;30:2051–2058. [PubMed] [Google Scholar]

117. Fiaccadori E., Maggiore U., Giacosa R. Enteral nutrition in patients with acute renal failure. Kidney Int. 2004;65:999–1008. [PubMed] [Google Scholar]

118. Barnert J., Dumitrascu D., Neeser G. Gastric emptying of a liquid meal in intensive care unit patients. Gastroenterology. 1998;114:A865. [Google Scholar]

119. Marik P.E., Zaloga G.P. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med. 2001;29:2264–2270. [PubMed] [Google Scholar]

120. Doig G.S., Heighes P.T., Simpson F. Early enteral nutrition reduces mortality in trauma patients requiring intensive care: a meta-analysis of randomised controlled trials. Injury. 2011;42:50–56. [PubMed] [Google Scholar]

121. Bost R.B., Tjan D.H., van Zanten A.R. Timing of (supplemental) parenteral nutrition in critically ill patients: a systematic review. Ann Intensive Care. 2014;4:31. [PMC free article] [PubMed] [Google Scholar]

122. Kopple J.D. McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr. 1997;65:1544–1557. [PubMed] [Google Scholar]

123. Druml W., Mitch W.E. Metabolic abnormalities in acute renal failure. Semin Dial. 1996;9:484–490. [Google Scholar]

124. Schneeweiss B., Graninger W., Stockenhuber F. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr. 1990;52:596–601. [PubMed] [Google Scholar]

125. Investigators N.-S.S., Finfer S., Liu B. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108–1118. [PubMed] [Google Scholar]

126. Fiaccadori E., Sabatino A., Morabito S. Hyper/hypoglycemia and acute kidney injury in critically ill patients. Clin Nutr. 2016;35:317–321. [PubMed] [Google Scholar]

127. Macias W.L., Alaka K.J., Murphy M.H. Impact of the nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure. JPEN J Parenter Enteral. Nutr. 1996;20:56–62. [PubMed] [Google Scholar]

128. Fiaccadori E., Maggiore U., Rotelli C. Effects of different energy intakes on nitrogen balance in patients with acute renal failure: a pilot study. Nephrol Dial Transplant. 2005;20:1976–1980. [PubMed] [Google Scholar]

129. Chima C.S., Meyer L., Hummell A.C. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol. 1993;3:1516–1521. [PubMed] [Google Scholar]

130. Leblanc M., Garred L.J., Cardinal J. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy. Am J Kidney Dis. 1998;32:444–453. [PubMed] [Google Scholar]

131. Salahudeen A.K., Kumar V., Madan N. Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol. 2009;4:1338–1346. [PMC free article] [PubMed] [Google Scholar]

Page 2